Table 1 Baseline clinical characteristics of the study groups
From: Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease
Variables | Acute coronary syndrome (n = 39) | Chronic stable angina (n = 40) | p value |
|---|---|---|---|
Sex ratio (male:female) | 37:1 | 37:1 | 1.000 |
Age, years median (IQR) | 53 (43–64) | 46 (42–61) | 0.806 |
Multiple vessel disease (n, %) | 22 (56.4Â %) | 30 (75.0Â %) | 0.082 |
Hypertension (n, %) | 23 (59.0Â %) | 32 (80.0Â %) | 0.042* |
Diabetes mellitus (n, %) | 17 (43.6Â %) | 22 (55.0Â %) | 0.311 |
Hyperlipidaemia (n, %) | 26 (66.7Â %) | 27 (67.5Â %) | 0.937 |
Cholesterol (mmol/L) median (IQR) | 4.8 (1.0) | 4.7 (1.1) | 0.562 |
LDL cholesterol (mmol/L) | 2.6 (2.1–3.6) | 2.7 (1.9–3.4) | 0.456 |
Triglycerides (mmol/L) median (IQR) | 1.4 (1.1–2.3) | 1.8 (1.7–2.5) | 0.006* |
Platelet count (×109/L) (mean ± SD) | 231.0 ± 60.1 | 250.0 ± 58.6 | 0.177 |
Creatinine (µmol/L) median (IQR) | 107 (99–119) | 99 (84–106) | 0.023* |
Statin (n, %) | 26 (66.7Â %) | 27 (67.5Â %) | 0.937 |
Smoking (n, %) | 14 (35.9Â %) | 16 (40.0Â %) | 0.707 |
Previous myocardial infarction (n, %) | 2 (5.1Â %) | 14 (35.0Â %) | 0.001* |